We are a health data and insights
business focused on metabolic disease.
Our Vision
Empower every person to understand and improve their health.
Our Mission
To build the world’s most comprehensive, rich metabolic data set enabling earlier identification and earlier intervention.
Our Values
Community
We create a supportive and harmonious work environment by being open, patient and celebrating each other.
Making a
Difference
Being part of positive change in the world is what drives us. Do your best for the patient, listen and measure our impact.
Commitment
We are dedicated to delivering our best work in the right way. Our team welcomes commitment in its healthiest form allowing wellbeing to be a priority.
Excellence
We stay informed and always strive to improve and create work we can be proud of. Delivering tangible results that reflect the outstanding talent of our team.
Inspiration
Seek opportunities and motivation to create momentum and enjoyment.
Ask questions and stay curious.
Respect
Consideration and respect for others and our resources allow us to build a culture of honesty and trust.
We are a dynamic team of experts, thought leaders and innovators; all motivated by the common goal to improve lives.
We began our journey in 2015 on a mission to improve the lives of those living with diabetes, since then, we have expanded our reach and expertise to allow us to offer real solutions to problems faced by patients and healthcare professsionals.
2015
Gendius formed
2018
Gestational Diabetes Mellitus research completed
2018
intellin goes live
The app and healthcare professional dashboard provide connected care for diabetic patients
2020
AstraZeneca partnership
2021
University of Nottingham partnership
2021
University of Manchester partnership
2021
Data Science team expanded
2022
HealthGate launched
Technology for diabetes risk prediction launched in the GCC through the new AstraZeneca patient support app, HealthGate
2022
First CSP publication
CKD Screening Prioritizer work publication goes live
2022
CSP presented at EASD
Validation work for the CKD Screening Prioritizer is presented at EASD
2023
CSP goes live
with over 100,000 patients screened, in the first 4 months
2023
Health Innovation Accelerator started
Funded by the Innovate grant, our partnership with Health Innovation Manchester uses the CSP to help access underserved populations